secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001213900-23-045748
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar receives Nasdaq notice for non-compliance with $1.00 minimum bid price rule
--------------------------------------------------------------------------------

- Notice dated May 26, 2023; stock closed below $1.00 for 30 consecutive business days.
- Company has until November 22, 2023 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may qualify for second 180-day period by transferring to Nasdaq Capital Market.
- Company intends to monitor bid price and evaluate options including possible reverse stock split.
- No immediate impact on listing; delisting possible if compliance not achieved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390023045748/0001213900-23-045748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390023045748/ea179697-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-045748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer